TY  - GEN
AU  - Hamdy,Neveen A T
TI  - Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis
SN  - 1472-4472
PY  - 2007///0801
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Denosumab
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Osteoporosis
KW  - drug therapy
KW  - RANK Ligand
KW  - Receptor Activator of Nuclear Factor-kappa B
KW  - immunology
KW  - Signal Transduction
KW  - drug effects
N1  - Publication Type: Journal Article; Review
ER  -